Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus

AIMS/HYPOTHESIS: People with diabetes have an increased cardiovascular risk with an accelerated development of atherosclerosis and an elevated mortality rate after myocardial infarction. Therefore, cardioprotective effects of glucose-lowering therapies are of major importance for the pharmacotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Kohlmorgen, Christina, Gerfer, Stephen, Feldmann, Kathrin, Twarock, Sören, Hartwig, Sonja, Lehr, Stefan, Klier, Meike, Krüger, Irena, Helten, Carolin, Keul, Petra, Kahl, Sabine, Polzin, Amin, Elvers, Margitta, Flögel, Ulrich, Kelm, Malte, Levkau, Bodo, Roden, Michael, Fischer, Jens W., Grandoch, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245397/
https://www.ncbi.nlm.nih.gov/pubmed/34131781
http://dx.doi.org/10.1007/s00125-021-05498-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245397/
https://www.ncbi.nlm.nih.gov/pubmed/34131781
http://dx.doi.org/10.1007/s00125-021-05498-0

Ejemplares similares